abstract |
The present invention relates to a liquid composition comprising a GLP-1 agonist and / or a pharmacologically acceptable salt thereof, an insulin and / or a pharmacologically acceptable salt thereof, and, optionally, at least one pharmaceutically acceptable excipient Wherein the composition comprises methionine as an adjunctive therapy using metformin, where appropriate. |